MAS1L and breast carcinoma: In normal breast tissue, RAS activity mainly relies on the alternative pathway (ACE-2/Ang 1-7/MASR), whilst in breast cancer tissue, the classical pathway (ACE/Ang II/AT1R) was the prominent (40).